Roche and Ionian Technologies Strike Product-Development Pact | GenomeWeb

NEW YORK (GenomeWeb News) – Roche Diagnostics will collaborate with molecular diagnostics company Ionian Technologies in an effort to identify new applications and customers for Ionian's technology.

Ionian said on Thursday that Roche will seek new opportunities for Ionian's NEAR Assay, a rapid isothermal nucleic acid amplification technology, in return for exclusive manufacturing rights if the new applications are commercialized.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.